Recce Ltd has released a press release.
Appendix 4C - quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Recce Launches Share Purchase Plan
- Response to ASX Price Query
- Recce Confirms Pre-IND Data Submission to US FDA
- Appendix 4E and Financial Report
- Recce Confirms Delivery by Intravenous Drip
Later from Recce Pharmaceuticals
- US FDA Grants Qualified Infectious Disease Product Designati
- AusIndustry Awards Recce Financial Support
- Data Submission & Further Communication Request with US FDA
- Recce Half Yearly Report and Appendix 4D
- Additional AU$861,590 R&D Tax Incentive Rebate Received
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals